Portfolio of Stem Cell Stocks
Here is a table of 10 stem cell stocks.
| 10 Stem Cell Stocks | ||
|---|---|---|
Name | Symbol | Recent Prices |
| Athersys | ATHX | |
| Brainstorm Cell Therapeutics | BCLI | |
| Caladrius Biosciences | CLBS | |
| Geron | GERN | |
| Pluristem Therapeutics | PSTI | |
| Sangamo Therapeutics | SGMO | |
| Seneca Biopharma | SNCA | |
| ThermoGenesis | THMO | |
| Vericel | VCEL | |
| VistaGen Therapeutics | VTGN | |
| Price charts from Alpha Vantage as of most recent close. | ||
Portfolio Values
To inspect the performance of the Stem Cell Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.The 9 stocks included in the portfolio computations are: ATHX, BCLI, CLBS, GERN, PSTI, SGMO, SNCA, THMO and VCEL. The current value of the portfolio assumes that $1,111.11 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. VTGN was excluded from the portfolio computations because of insufficient price data.
The current value of a $10,000 investment is $33,564. The percent return is 235.64%. The annualized return is 27.40%.
Portfolio Value Chart for Last 100 Daily Closes
Values of User-Selected Sample Portfolios: Discover the Most and Least Profitable Sample Portfolios
Related Portfolios
Portfolio of Gene Editing (CRISPR) Stocks